CHARLES THEUER
CIK 1631338 · PRESIDENT AND CEO · last filed 2025-12-16
CHARLES THEUER is a PRESIDENT AND CEO who has filed 68 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider exercised options covering $10.6K of FDMT on Dec 16, 2025. Across all open-market trades the lifetime net is +$694.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $368.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$368.1K
3
68
$694.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FDMT | Director | 41,684 | $8.83 | $368.1K | $0 | 6 | 2025-12-16 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | 14,677 | $0.53 | $7.7K | $0 | 9 | 2024-06-24 |
| Tracon Pharmaceuticals, Inc. (TCON) Delisted | PRESIDENT AND CEO | 402,917 | $0.03 | $13.0K | $694.3K | 42 | 2024-03-13 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-16 | FDMT | Exer (M) | +9,333 | $10.6K | EDGAR |
| 2025-06-20 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2024-03-13 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Grant (A) | +7,000 | $948 | EDGAR |
| 2023-06-30 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Buy (P) | +50,999 | $37.9K | EDGAR |
| 2023-03-02 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Buy (P) | +5,000 | $7.6K | EDGAR |
| 2023-02-03 | Tracon Pharmaceuticals, Inc. (TCON) Delisted | Grant (A) | — | $0 | EDGAR |